Why the study?
Does a single oral dose of 600 mg aspirin reduce platelet aggregation response to arachidonic acid in volunteers?
Does a single oral dose of 600 mg aspirin reduce platelet aggregation response to arachidonic acid in volunteers?
A single 600 mg dose of aspirin completely inhibits arachidonic acid-induced platelet aggregation for 4 days, suggesting an effect on platelet precursors in the bone marrow in addition to circulating platelets.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for aspirin's effects on platelet precursors; should not yet change clinical dosing without randomized confirmation.
1 The platelet aggregation response to arachidonic acid ex vivo was measured in six volunteers daily before and for 10 days after a single oral dose of 600 mg aspirin. 2 Arachidonic acid induced aggregation of platelets from all subjects before aspirin and aggregation occurred after an interval which varied inversely with the concentration of arachidonic acid. No aggregation occurred for 4 days after aspirin; a reduced response, compared with pre-aspirin values, was obtained on the 5th, 6th and 8th day. The values on days 7, 9 and 10 were not consistently different from the pre-aspirin values. In 6 subjects 24 h after aspirin ingestion the addition of 10--25% v/v normal platelets restored the aggregation response. 3 It is concluded that aspirin has an effect on the platelet precursors in the marrow in addition to its effect on circulating platelets.
No takes yet. Share an insight, caveat, or question.
Bye et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: